© 1995 by Biometrika Trust
Articles |
Model misspecification in proportional hazards regression
1 Fred Hutchinson Cancer Research Center 1124 Columbia Street, Seattle, Washington 98104, U.S.A.
2 Department of Biostatistics, University of Washington Seattle, Washington 98195, U.S.A.
Received for publication 1 May 1992.
Revision received 1 March 1995.
| Abstract |
|---|
The proportional hazards model is frequently used to evaluate the effect of treatment on failure time events in randomised clinical trials. Concomitant variables are usually available and may be considered for use in the primary analyses under the assumption that incorporating them may reduce bias or improve efficiency. In this paper we consider two approaches to including covariate information: regression modelling and stratification. We focus on the setting where covariate effects are nonproportional and we compare the bias, efficiency and coverage properties of these approaches. These results indicate that our intuition based on linear model analysis of covariance is misleading. Covariate adjustment in proportional hazards models has little effect on the variance but may significantly improve the accuracy of the treatment effect estimator.
Key Words: Analysis of covariance Model misspecification Omitted covariates Proportional hazards
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Meira-Machado, J. de Una-Alvarez, C. Cadarso-Suarez, and P. K Andersen Multi-state models for the analysis of time-to-event data Statistical Methods in Medical Research, April 1, 2009; 18(2): 195 - 222. [Abstract] [PDF] |
||||
![]() |
Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook J Natl Cancer Inst Monographs, August 1, 1998; 1998(24): 1 - 28. [Full Text] |
||||

